Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin analogues vs human insulin and severe hypoglycaemia in hypoglycaemia-prone type 1 diabetes
2006-003630-15Phase 4Completed
- Sponsor
- Steno Diabetes Center
- Start
- Jan 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4 trial of insulin detemir, insulin aspart, isophane insulin and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Steno Diabetes Center. Primary endpoint: Incidence of severe hypoglycaemia from 3 to 12 months of treatment. Started Jan 2007; status: completed.
02
Drugs
insulin detemirinsulin aspartisophane insulinhuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2006-003630-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003630-15.